Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
19 March 2019 | Story Xolisa Mnukwa
Career Services
Front row from left to right: Magdalena Matthys (intern), Lavhelesani Mpofu (intern). Back row from left to right: Carmenita Redcliffe (Chief Officer: Company Relations), Nthabiseng Khota (intern), Belinda Janeke (Head of Career Services and Student Relations).
The Career Services office opened its facilities in 2007 as a help desk on the UFS Bloemfontein Campus at the Sasol Library, due to the increasing number of students looking for employment opportunities. The team has grown over the years and now consists of two chief officers, Belinda Janeke and Carmenita Redcliffe, two research assistants, 15 volunteers and seven career ambassadors.  The portfolio of company relations is the latest addition to the team that runs a number of new initiatives and events that aim to enhance overall marketing and services offered by the department.

In January this year, Career Services hosted a corporate breakfast in Johannesburg.  Rector and Vice-Chancellor, Prof Francis Petersen, led a delegation consisting of Vice Rector: Institutional Change, Student Affairs, Prof Puleng LenkaBula, Dean of Student Affairs, Pura Mgolombane, Director of Institutional Advancement, and Director of Communication and Marketing, Annamia van den Heever, and Lacea Loader respectively . The event was an initiative that sought to motivating companies, donors and funders to employ and fund top UFS graduates.

According to Belinda Janeke, keeping UFS students informed about career opportunities and equipping them with the skills and grit to make them employable, finding employment or starting their own business is the department’s ultimate goal.



News Archive

Heart-valve studies receive international recognition
2017-07-11

 Description: Heart-valve studies Tags: Heart-valve studies  

Prof Francis Smit, Head of the Department of
Cardiothoracic Surgery at the UFS, and Manager of the
Robert WM Frater Cardiovascular Research Centre, with
Kyle Davis, Mechanical Engineer at the centre.
Photo: Rulanzen Martin

Three heart-valve studies which have been developed at the Robert WM Frater Cardiovascular Research Centre at the School of Medicine at the University of the Free State (UFS) were recently presented in Monte Carlo at the conference of the prestigious global Heart Valve Society (HVS).

These studies are all headed by Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS, and Manager of the Robert WM Frater Cardiovascular Research Centre.
Prof Smit says the HVS is a combination of the former heart-valve societies of Europe and the US. “Studies on heart-valve disease, heart-valve-related products and operations, as well as the design and development of new valves were presented. There are both clinical and development divisions.

He says the study in which the hemodynamics of their redesigned mechanical poppet valve was compared to a commercial bi-leaflet mechanical heart valve, was named as the best poster presentation in the experimental valve development and numerical flow dynamics division. The study, which was presented by Kyle Davis, mechanical engineer at the centre, competed against some of the best heart-valve research units in the world.

The redesigned valve, based on the 1960s Cape Town poppet valve, has the potential to provide a low-cost solution for mechanical heart-valve replacement. It is possible to produce the titanium ring with 3-D printers and is, together with the silicon poppet valve, extremely inexpensive compared to current mechanical valve-manufacturing processes.
The advantages of this valve over current mechanical valves is that, due to the effective and laminar flow characteristics, as well as the simple locking mechanisms, there is a reduced chance of valve thrombosis, and the need for anti-clotting drugs is therefore limited.

It was also confirmed that the new valve more than meets the published FDA (Federal Drug Agency) requirements, which determine the minimum standards of valves for human use in the US.

The redesigned valve also has a very low platelet activation impact, which is responsible for platelet thrombosis and leads to valve thrombosis or strokes. This valve is another heart-valve project by the centre, which is also in the process of evaluating a tri-leaflet polyurethane valve developed by them.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept